Latest Breaking News On - ஊக்கத்தொகை திட்டங்கள் - Page 1 : comparemela.com
SilverCrest Reports Q2 2021 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Cryo Cell International : Employment Agreement with Oleg Mikulinsky (Form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Olivier Bargain, Ulugbek Aminjonov
Four decades ago, Robert Lucas rocked economics with a simple observation: taxes and other government interventions in the private economy affect not only the costs and benefits of actions citizens may take (as intended), but also their beliefs about the future actions of others (including the government), possibly in counterproductive ways. For example, announcing stiffer penalties for non-payment of taxes provides an incentive to pay up; but it also may convey the information that non-compliance is common, leading formerly honest citizens to cheat.
Lucas’ point was that policymaking is not simply resetting the dials on a given model of how the economy works, but instead changing the structure of the model itself (Lucas 1976). In 1994, Henry Aaron of the Brookings Institution pointed to “the failure of economists to take the formation of preferences seriously”, and suggested that the Lucas critique be extended to cover preferences as well
Renewi plc: Blocklisting Interim Review
DJ Renewi plc: Blocklisting Interim Review
Renewi plc (RWI)
Renewi plc: Blocklisting Interim Review
01-Apr-2021 / 11:37 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
BLOCK LISTING SIX MONTHLY RETURN
Date: 1 April 2021
Name of applicant: Renewi plc
Name of scheme: Renewi plc Long Term Incentive Plans
Period of return: From: 01/10/2020 To: 31/03/2021
Balance of unallotted securities under scheme(s) from previous return: 2,162,130
Plus: The amount by which the block scheme(s) has been increased since the date of the last Nil
return (if any increase has been applied for):
The Union Cabinet on Wednesday approved production-linked incentive (PLI) scheme for pharmaceuticals over a period of eight years (FY21-FY29). It will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The total quantum of incentive under the scheme is about Rs 15,000 crore.
The manufacturers of pharmaceutical goods registered in India will be grouped based on their global manufacturing revenue to decide the target elements for the scheme. The scheme is expected lead to the total incremental sales of Rs 2.94 trillion and exports worth Rs 1.96 trillion are estimated during six years from FY23 to FY28. It is also expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.
vimarsana © 2020. All Rights Reserved.